Evolus Goodwill

Evolus (EOLS) currently reports a goodwill of $21M as of June 2026. That compares with $21M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Evolus's goodwill history and peer comparisons.

Evolus's goodwill was unchanged from $21M to $21M — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evolus reported $21M in goodwill as of June 2026. That compares with $21M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evolus, and consider following EOLS for alerts when major investors trade the stock.

Evolus is classified in the Healthcare sector. On goodwill, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EOLS with unrelated industries.